RIO DE JANEIRO, Aug. 3 Amil Participacoes S.A. (BM&FBovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3 SA), the largest healthcare company in Brazil, informs that Fitch attributed to Amilpar, National Long-Term Rating "AA-(bra)", with stable outlook. The obtaining of Amilpar's corporate rating is aligned with the strategy of conversion of the Company's current short term debt into long term.
To access the .pdf version of the document visit our website at www.amilpar.com.br/ir
Amil Participacoes S.A. is the largest healthcare company in Brazil, according to the ANS, currently assisting over 5 million members in the states of Sao Paulo, Rio de Janeiro, Parana, Minas Gerais, Pernambuco, Bahia and in Distrito Federal. It is also the managed care organization with the largest provider network in the country, including over (i) 3,600 hospitals; (ii) 62,000 polyclinics and outpatient facilities; and (iii) 11,200 laboratories and diagnostic imaging centers. Amil began its activities in 1978 and offers a wide range of healthcare plans for small, medium and large companies, as well as plans for individuals from all income segments, offering its members access to carefully selected healthcare service providers.
IR Contact Erwin Kleuser Investor Relations Officer Phone: +55 (21) 3805-1155 [email protected]